215 related articles for article (PubMed ID: 1755261)
1. [Tumor recurrence following negative second-look laparotomy in ovarian carcinoma].
Schneider J; Barbazan M; Centeno M; Montoya F; Neyro JL; Rodriguez-Escudero FJ
Zentralbl Gynakol; 1991; 113(22):1246-50. PubMed ID: 1755261
[TBL] [Abstract][Full Text] [Related]
2. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
[TBL] [Abstract][Full Text] [Related]
5. Results of second-look laparotomy in patients with early-stage ovarian carcinoma.
Walton L; Ellenberg SS; Major F; Miller A; Park R; Young RC
Obstet Gynecol; 1987 Nov; 70(5):770-3. PubMed ID: 3658289
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the role of second-look surgery in ovarian cancer.
Chambers SK; Chambers JT; Kohorn EI; Lawrence R; Schwartz PE
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557
[TBL] [Abstract][Full Text] [Related]
7. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
[TBL] [Abstract][Full Text] [Related]
8. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
9. Predictors and outcomes of recurrent disease after a negative second look laparotomy.
Ayhan A; Gultekin M; Dursun P; Dogan NU; Aksan G; Guven S; Yuce K
J Surg Oncol; 2008 Mar; 97(3):226-30. PubMed ID: 18050284
[TBL] [Abstract][Full Text] [Related]
10. Times and sites of relapses after negative second look in advanced epithelial ovarian cancer.
Maggino T; Gadducci A; Romagnolo C; Fanucchi A; Fioretti P
Eur J Surg Oncol; 1994 Apr; 20(2):146-50. PubMed ID: 8181580
[TBL] [Abstract][Full Text] [Related]
11. Consolidative 32P after second-look laparotomy for ovarian carcinoma.
Condra KS; Mendenhall WM; Morgan LS; Marcus RB
Radiat Oncol Investig; 1998; 6(2):97-102. PubMed ID: 9572686
[TBL] [Abstract][Full Text] [Related]
12. [Is there a place for 2nd look laparotomy in the treatment of ovarian cancers?].
Stöckle E; Bussières E; Stöckle M; Avril A; Thomas L; Chauvergne J; Brunet R; Pigneux J; Marée D
Bull Cancer; 1993 Jul; 80(7):629-38. PubMed ID: 8204944
[TBL] [Abstract][Full Text] [Related]
13. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
[TBL] [Abstract][Full Text] [Related]
14. [Second-look laparotomy or the search for curable stage III FIGO ovarian epitheliomas. Apropos of a series of 35 cases].
Martel P; David JM; Zervoudis S; Riba M; Bugat R
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(5):633-9. PubMed ID: 4067219
[TBL] [Abstract][Full Text] [Related]
15. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
16. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
[TBL] [Abstract][Full Text] [Related]
17. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.
Landoni F; Pellegrino A; Cormio G; Milani R; Maggioni A; Mangioni C
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):233-7. PubMed ID: 9512334
[TBL] [Abstract][Full Text] [Related]
18. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
19. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
20. Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy?
Linasmita V; Wilailak S; Thakkinstian A; Srisupundit S; Tangtrakul S; Israngura N; Bullangpoti S
J Med Assoc Thai; 2001 Jul; 84(7):958-65. PubMed ID: 11759976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
